After the COVID-19 Crisis: Update on Complex Infectious Disease Issues in the Intensive Care Unit, An Issue of Infectious Disease Clinics of North America
Contains 13 practice-oriented topics including timing and spectrum of antibiotic treatment for suspected sepsis and septic shock; preparing an ICU for a lethal viral respiratory pandemic; rapid implementation of a system-level ICU pandemic surge staffing amidst quarantined staff and infection control barriers; management of serious SARS-CoV-2 infection with immunotherapies; supportive care in patients with critical COVID-19; and more.
Provides in-depth clinical reviews on complex infectious diseases issues in the ICU, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
|Author Information||Edited by Naomi P. O'Grady, MD, Johns Hopkins School of Medicine, and the Critical Care Medicine Department, NIH, Baltimore, MD and Sameer S. Kadri, MD, Head of Clinical Epidemiology Section, Critical Care Medicine Department, NIH Clinical Center, Bethesda, MD|
|Table of Content||Timing and Spectrum of Antibiotic Treatment for Suspected Sepsis and Septic Shock: Why so Controversial?
Cytokine Release Syndrome and Sepsis: Analogous Clinical Syndromes with Distinct Causes and Challenges in Management
Preparing the Intensive Care Unit for a Lethal Viral Respiratory Pandemic
Management of Severe and Critical COVID-19 Infection with Immunotherapies
Supportive Care in Patients with Critical Coronavirus Disease 2019
Management of Highly Resistant Gram-Negative Infections in the Intensive Care Unit in the Era of Novel Antibiotics
Management of Unique Pneumonias Seen in the Intensive Care Unit
Management of Common Postoperative Infections in the Surgical Intensive Care Unit
ICU Management of Invasive b-Hemolytic Streptococcal Infections
Severe Clostridioides difficile Infection in the Intensive Care Unit-Medical and Surgical Management
Uses of Procalcitonin as a Biomarker in Critical Care Medicine